Companies: 10,795·Total market cap: $144.5T
ADC Therapeutics S.A.

ADC Therapeutics S.A.

ADCTNYSEHealthcare● Active
$1.03
$-0.29(-21.97%)
Market Cap$131006730
P/E Ratio
52W High$4.98
52W Low$1.02

ADC Therapeutics S.A. (ADCT) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · ADCT · as of Mar 10, 2026

Latest filing snapshot

188
-75-28.52%vs prior year

ADC Therapeutics S.A. (ADCT) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing

SEC 10-K·Period end: 2025-12-31·Full-time · Global
Total Employees
188
Change (1Y)
-75
Growth % (1Y)
-28.52%
Revenue / Employee
$432.8K
Net Income / Employee
$-758.6K
Market Cap
$131M

ADCT Employee Count

2020 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2026-03-10188-75-28.52%
2025-03-27263-10-3.66%
2024-03-13273-44-13.88%
2023-03-15317+5+1.60%
2022-03-17312+104+50.00%
2021-03-18208

Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology
#SymbolCompanyEmployees
#1
Autolus Therapeutics plc
AUTL
Autolus Therapeutics plc
647
#2
Bicycle Therapeutics plc
BCYC
Bicycle Therapeutics plc
305
#3
4D Molecular Therapeutics, Inc.
FDMT
4D Molecular Therapeutics, Inc.
227
#4
ADC Therapeutics S.A.
ADCT
ADC Therapeutics S.A.YOU
188
#5
Alumis Inc. Common Stock
ALMS
Alumis Inc. Common Stock
168
#6
Lexicon Pharmaceuticals, Inc.
LXRX
Lexicon Pharmaceuticals, Inc.
103
#7
Lineage Cell Therapeutics, Inc.
LCTX
Lineage Cell Therapeutics, Inc.
70
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · ADCT peer comparison

About ADCT employees

ADCT Employees · Headcount

ADC Therapeutics S.A. (ADCT) employee data is sourced from the annual SEC 10-K filing. As of 2025, ADC Therapeutics S.A. had 188 full-time employees globally. Full-time employees only. Global consolidated headcount.

ADC Therapeutics S.A. employs 188 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $432,750, reflecting the company's operational efficiency.

ADC Therapeutics S.A.'s workforce decreased by 75 (28.52%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

ADC Therapeutics S.A.'s revenue per employee of $432,750 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Frequently Asked Questions

ADCT Employees · 5 questions

As of the latest SEC 10-K filing (2025), ADC Therapeutics S.A. had 188 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

ADC Therapeutics S.A. employee counthow many employees does ADC Therapeutics S.A. haveADCT total employees 2025

Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-10